Advertisement
Advertisement
U.S. markets open in 2 hours 59 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Adynxx, Inc. (ADYX)

Other OTC - Other OTC Delayed Price. Currency in USD
Visitors trend2W10W9M
0.00010.0000 (0.00%)
At close: 03:39PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0001
Open0.0001
Bid0.0000 x 800
Ask0.0000 x 1300
Day's Range0.0001 - 0.0001
52 Week Range0.0001 - 0.0003
Volume4
Avg. Volume464
Market Cap87,118
Beta (5Y Monthly)2.35
PE Ratio (TTM)N/A
EPS (TTM)-1.8190
Earnings DateNov 14, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 06, 2019
1y Target Est2.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ADYX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ADYNXX INC
    INGN: What does Argus have to say about INGN?INOGEN INC has an Investment Rating of HOLD; a target price of $24.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • PR Newswire

    NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

    NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today the appointment of Scott Henry, CFA as a new independent director to the Company's Board of Directors (the "Board"), effective immediately. Mr. Henry will also serve as a member of the Board's Audit Committee.

  • GlobeNewswire

    NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

    LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that it has launched a new product dubbed Turfguard, a unique hydrogel dressing for soothing turf burn and protecting athletic wounds. Turfguard’s sterile silver patches, cleared by the U.S. Food and Drug Administration, kill 99 percent of staph, MRSA an

  • PR Newswire

    NEXGEL Announces Share Repurchase Program

    NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that its Board of Directors has approved a share repurchase program, effective immediately, with authorization to purchase up to $500,000 of the Company's common shares.

Advertisement
Advertisement